According to the American Cancer Society, the 5-year survival rate for stage 4 melanoma is 35%. This means that an estimated 35% of people with stage 4 melanoma will be alive 5 years after diagnosis.

Close to 100 per cent of people who are diagnosed with non-melanoma skin cancer survive for at least five years after their diagnosis, according to a new report. For melanoma, the more serious ...

Although melanoma primarily affects fair-skinned people, people with darker skin are also at risk but often go undiagnosed ...

A new study links changes in frailty, a measure of decreased physiological capacity that leads to fatigue, slow walking, ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

Uveal melanoma, which primarily affects Caucasian patients, is the most common primary intraocular tumor in adults2 that most ...

Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

Sun worshippers were urged to protect themselves in the glorious early spring sunshine amid warnings that a person dies in ...

Droplet digital PCR measurements of circulating tumor (ct)DNA to assess minimal residual disease before the initiation of adjuvant therapy and during follow-up for patients with resected stage III ...

Although the tilsotolimod plus ipilimumab treatment did not meet its co-primary endpoint, these results are a valuable addition to the literature with respect to second-line treatment options in this ...

The decision to choose systemic adjuvant therapy warrants careful discussion on its benefits and risks,” researchers wrote.